So-called “cornerstone” investors from outside Asia have accounted for a record 46% of the shares sold in biotech initial public offerings (IPOs) in Hong Kong so far this year, according to data …
( read original story …)
The HongKong News
So-called “cornerstone” investors from outside Asia have accounted for a record 46% of the shares sold in biotech initial public offerings (IPOs) in Hong Kong so far this year, according to data …
( read original story …)